Patterns of rpoC Mutations in Drug-Resistant Mycobacterium tuberculosis Isolated from Patients in South Korea

Patterns of rpoC Mutations in Drug-Resistant Mycobacterium tuberculosis Isolated from Patients in South Korea

Background Rifampicin (RFP) is one of the principal first-line drugs used in combination chemotherapies against Mycobacterium tuberculosis, and its use has greatly shortened the duration of chemotherapy for the successful treatment of drug-susceptible tuberculosis. Compensatory mutations have bee...

Full description

Bibliographic Details
Main Authors: Yeo Jun Yun, Ph.D., Jong Seok Lee, Ph.D., Je Chul Yoo, M.D., Ph.D., Eunjin Cho, Dahee Park, Yoon-Hoh Kook, M.D., Ph.D., Keun Hwa Lee, Ph.D.
Format: Article
Language:English
Published: The Korean Academy of Tuberculosis and Respiratory Diseases 2018-03-01
Series:Tuberculosis and Respiratory Diseases
Subjects:
mycobacterium tuberculosis
drug resistance
multiple
beta' subunit of rna polymerase
mutation
Online Access:https://e-trd.org/search.php?where=aview&id=10.4046/trd.2017.0042&code=0003TRD&vmode=FULL

Internet

https://e-trd.org/search.php?where=aview&id=10.4046/trd.2017.0042&code=0003TRD&vmode=FULL

Similar Items